{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:01:49Z","timestamp":1792504909316,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006209","name":"Radboud University Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00277-018-3436-0","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T05:51:20Z","timestamp":1533534680000},"page":"2117-2128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016"],"prefix":"10.1007","volume":"97","author":[{"given":"Alexandar","family":"Tzankov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos","family":"Leguit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"van der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Gianelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konnie M.","family":"Hebeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"3436_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00277-017-2947-4","volume":"96","author":"A Tzankov","year":"2017","unstructured":"Tzankov A, Hebeda K, Kremer M et al (2017) Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016. Ann Hematol 96:765\u2013777","journal-title":"Ann Hematol"},{"key":"3436_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0740-2570(03)00030-3","volume":"20","author":"KL Chang","year":"2003","unstructured":"Chang KL, Gaal KK, Huang Q, Weiss LM (2003) Histiocytic lesions involving the bone marrow. Semin Diagn Pathol 20:226\u2013236","journal-title":"Semin Diagn Pathol"},{"key":"3436_CR3","volume-title":"Histiocytic disorders of children and adults","author":"SR Weitzman","year":"2010","unstructured":"Weitzman SR, Egeler M (2010) Histiocytic disorders of children and adults. University Press, Cambridge"},{"key":"3436_CR4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3109\/10428194.2014.946028","volume":"56","author":"Y Fedoriw","year":"2014","unstructured":"Fedoriw Y, Kim YS, Vergilio J-A et al (2014) BRAF V600E mutation-specific immunohistochemistry is a rare finding and dendritic cell- and histiocytic-derived tumors. Leuk Lymph 56:1132\u20131133","journal-title":"Leuk Lymph"},{"issue":"10","key":"3436_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","volume":"30","author":"S Garces","year":"2017","unstructured":"Garces S, Medeiros LJ, Patel KP et al (2017) Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 30(10):1367\u20131377","journal-title":"Mod Pathol"},{"key":"3436_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/modpathol.2017.174","volume":"31","author":"X Tian","year":"2018","unstructured":"Tian X, Jie X, Fletcher C et al (2018) Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1\/2-related, but not MYC- or p-STAT3-related cell signaling. Mod Pathol 31:553\u2013561","journal-title":"Mod Pathol"},{"issue":"11","key":"3436_CR7","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA et al (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116(11):1919\u20131923","journal-title":"Blood"},{"key":"3436_CR8","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","volume":"120","author":"J Haroche","year":"2012","unstructured":"Haroche J, Charlotte F, Arnaud L et al (2012) High prevalence of BRAF V600E mutations in Erdheim\u2013Chester disease but not in other non-Langerhans cell histiocytoses. Blood 120:2700\u20132703","journal-title":"Blood"},{"key":"3436_CR9","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","volume":"124","author":"NA Brown","year":"2014","unstructured":"Brown NA, Furtado LV, Betz BL et al (2014) High prevalence of somatic MAP2K1 mutations in BRAF V600E\u2013negative Langerhans cell histiocytosis. Blood 124:1655\u20131658","journal-title":"Blood"},{"key":"3436_CR10","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","volume":"123","author":"DS Nelson","year":"2014","unstructured":"Nelson DS, Quispel W, Badalian-Very G et al (2014) Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood 123:3152\u20133155","journal-title":"Blood"},{"key":"3436_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","volume":"6","author":"EL Diamond","year":"2016","unstructured":"Diamond EL, Durham BH, Haroche J et al (2016) Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 6:154\u2013165","journal-title":"Cancer Discov"},{"issue":"22","key":"3436_CR12","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S et al (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672\u20132681","journal-title":"Blood"},{"key":"3436_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12105-016-0709-6","volume":"10","author":"V Shanmugam","year":"2016","unstructured":"Shanmugam V, Margolskee E, Kluk M et al (2016) Rosai-Dorfman disease harboring an activating KRAS K117N missense mutation. Head Neck Pathol 10:394\u2013399","journal-title":"Head Neck Pathol"},{"key":"3436_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00428-017-2173-4","volume":"471","author":"MS Matter","year":"2017","unstructured":"Matter MS, Bihl M, Juskevicius D, Tzankov A (2017) Is Rosai-Dorfman disease a reactive process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease. Virchows Arch 471:545\u2013547","journal-title":"Virchows Arch"},{"key":"3436_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","volume":"29","author":"I Maric","year":"2005","unstructured":"Maric I, Pittaluga S, Dale JK et al (2005) Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 29:903\u2013911","journal-title":"Am J Surg Pathol"},{"key":"3436_CR16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/MOP.0000000000000032","volume":"25","author":"JB Oliveira","year":"2013","unstructured":"Oliveira JB (2013) The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr 25:722\u2013729","journal-title":"Curr Opin Pediatr"},{"key":"3436_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1309\/AJCP4ZDKJ4ICOUAT","volume":"139","author":"GN Flavia","year":"2013","unstructured":"Flavia GN, Rosado MD, Kim AS (2013) Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol 139:713\u2013727","journal-title":"Am J Clin Pathol"},{"key":"3436_CR18","first-page":"466","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SA Pileri","year":"2017","unstructured":"Pileri SA, Jaffe R, Facshetti F et al (2017) Histiocytic and dendritic cell neoplasms. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, pp 466\u2013482"},{"key":"3436_CR19","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/01.pas.0000209846.52046.62","volume":"30","author":"Q Huang","year":"2006","unstructured":"Huang Q, Chang KL, Weiss LM (2006) Extranodal Rosai-Dorfman disease involving the bone marrow: a case report. Am J Surg Pathol 30:1189\u20131192","journal-title":"Am J Surg Pathol"},{"key":"3436_CR20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/PAS.0b013e3181ea50b2","volume":"34","author":"EG Demicco","year":"2010","unstructured":"Demicco EG, Rosenberg AE, Bjornsson J et al (2010) Primary Rosai-Dorfman disease of bone: a clinicopathologic study of 15 cases. Am J Surg Pathol 34:1324\u20131333","journal-title":"Am J Surg Pathol"},{"key":"3436_CR21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation-2015.1.571","volume":"2015","author":"J Haroche","year":"2015","unstructured":"Haroche J, Abla O (2015) Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Hematology Am Soc Hematol Educ Program 2015:571\u2013578","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3436_CR22","doi-asserted-by":"publisher","first-page":"46065","DOI":"10.18632\/oncotarget.17521","volume":"8","author":"R Chakraborty","year":"2017","unstructured":"Chakraborty R, Hampton OA, Abhyankar H et al (2017) Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma. Oncotarget 8:46065\u201346070","journal-title":"Oncotarget"},{"key":"3436_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajoc.2017.09.004","volume":"9","author":"P Meyer","year":"2017","unstructured":"Meyer P, Graeff E, Kohler C et al (2017) Juvenile xanthogranuloma involving concurrent iris and skin: Clinical, pathological and molecular pathological evaluations. Am J Ophthalmol Case Rep 9:10\u201313","journal-title":"Am J Ophthalmol Case Rep"},{"key":"3436_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.humpath.2017.04.026","volume":"69","author":"P Techavichit","year":"2017","unstructured":"Techavichit P, Sosothikul D, Chaichana T et al (2017) BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma. Hum Pathol 69:118\u2013122","journal-title":"Hum Pathol"},{"key":"3436_CR25","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jaad.2016.12.012","volume":"76","author":"C Liy-Wong","year":"2017","unstructured":"Liy-Wong C, Mohammed J, Carleton A et al (2017) The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study. J Am Acad Dermatol 76:1084\u20131087","journal-title":"J Am Acad Dermatol"},{"key":"3436_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjh.13247","volume":"169","author":"ML Berres","year":"2015","unstructured":"Berres ML, Merad M, Allen CE (2015) Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol 169:3\u201313","journal-title":"Br J Haematol"},{"issue":"5","key":"3436_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.hoc.2015.06.003","volume":"29","author":"M Collin","year":"2015","unstructured":"Collin M, Bigley V, McClain KL, Allen CE (2015) Cell(s) of origin of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 29(5):825\u2013838","journal-title":"Hematol Oncol Clin North Am"},{"key":"3436_CR28","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/S1470-2045(17)30031-1","volume":"18","author":"J Haroche","year":"2017","unstructured":"Haroche J, Cohen-Aubart F, Rollins BJ et al (2017) Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol 18:e113\u2013ee25","journal-title":"Lancet Oncol"},{"key":"3436_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20130977","volume":"211","author":"ML Berres","year":"2014","unstructured":"Berres ML, Lim KP, Peters T et al (2014) BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med 211:669\u2013683","journal-title":"J Exp Med"},{"key":"3436_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00277-017-3145-0","volume":"97","author":"S Haefliger","year":"2018","unstructured":"Haefliger S, Bihl M, Krasniqi F, Tzankov A (2018) PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma. Ann Hematol 97:355\u2013357","journal-title":"Ann Hematol"},{"issue":"5","key":"3436_CR31","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jpeds.2014.07.063","volume":"165","author":"SJ Simko","year":"2014","unstructured":"Simko SJ, Garmezy B, Abhyankar H et al (2014) Differentiating skin-limited and multisystem Langerhans cell histiocytosis. J Pediatr 165(5):990\u2013996","journal-title":"J Pediatr"},{"key":"3436_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ejh.12755","volume":"97","author":"J Ansari","year":"2016","unstructured":"Ansari J, Naqash AR, Munker R et al (2016) Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment. Eur J Haematol 97:9\u201316","journal-title":"Eur J Haematol"},{"key":"3436_CR33","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","volume":"111","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Arber DA, Pittaluga S et al (2008) Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 111:5433\u20135439","journal-title":"Blood"},{"key":"3436_CR34","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1038\/leu.2014.167","volume":"28","author":"P Brunner","year":"2014","unstructured":"Brunner P, Rufle A, Dirnhofer S et al (2014) Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor. Leukemia 28:1937\u20131940","journal-title":"Leukemia"},{"key":"3436_CR35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00428-017-2176-1","volume":"471","author":"F Facchetti","year":"2017","unstructured":"Facchetti F, Pileri SA, Lorenzi L et al (2017) Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Arch 471:467\u2013489","journal-title":"Virchows Arch"},{"key":"3436_CR36","doi-asserted-by":"crossref","first-page":"78355","DOI":"10.18632\/oncotarget.13058","volume":"7","author":"W Huang","year":"2016","unstructured":"Huang W, Qiu T, Zeng L et al (2016) High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms. Oncotarget 7:78355\u201378362","journal-title":"Oncotarget"},{"key":"3436_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0046-8177(90)90028-4","volume":"21","author":"SH Ment De","year":"1990","unstructured":"De Ment SH (1990) Association between mediastinal germ cell tumors and hematologic malignancies: an update. Hum Pathol 21:699\u2013703","journal-title":"Hum Pathol"},{"key":"3436_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/jnci\/92.1.54","volume":"92","author":"JT Hartmann","year":"2000","unstructured":"Hartmann JT, Nichols CR, Droz JP et al (2000) Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Nat Cancer Inst 92:54\u201361","journal-title":"J Nat Cancer Inst"},{"key":"3436_CR39","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1212\/WNL.0000000000000880","volume":"83","author":"A Idbaih","year":"2014","unstructured":"Idbaih A, Mokhtari K, Emile JF et al (2014) Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology 83:1478\u20131480","journal-title":"Neurology"},{"key":"3436_CR40","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MOH.0000000000000256","volume":"23","author":"BH Durham","year":"2016","unstructured":"Durham BH, Diamond EL, Abdel-Wahab O (2016) Histiocytic neoplasms in the era of personalized genomic medicine. Curr Opin Hematol 23:416\u2013425","journal-title":"Curr Opin Hematol"},{"key":"3436_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1182\/blood-2016-09-740217","volume":"129","author":"TM Nordmann","year":"2017","unstructured":"Nordmann TM, Juengling FD, Recher M et al (2017) Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations. Blood 129:879\u2013882","journal-title":"Blood"},{"key":"3436_CR42","unstructured":"The mutation data was obtained from the Sanger Institute Catalogue Of Somatic Mutations In Cancer http:\/\/cancer.sanger.ac.uk\/cosmic\/mutation\/overview?id=584"},{"key":"3436_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.6004\/jnccn.2017.0007","volume":"15","author":"PL Greenberg","year":"2017","unstructured":"Greenberg PL, Stone RM, Al-Kali A et al (2017) Myelodysplastic syndromes, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 15:60\u201387","journal-title":"J Natl Compr Cancer Netw"},{"key":"3436_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","volume":"41","author":"SA Pileri","year":"2002","unstructured":"Pileri SA, Grogan TM, Harris NL et al (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41:1\u201329","journal-title":"Histopathology"},{"key":"3436_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.53.1","volume":"53","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Nakamura S (2013) Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop 53:1\u20138","journal-title":"J Clin Exp Hematop"},{"key":"3436_CR46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/107327481402100405","volume":"21","author":"S Dalia","year":"2014","unstructured":"Dalia S, Shao H, Sagatys E, Cualing H, Sokol L (2014) Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment. Cancer Control 21:290\u2013300","journal-title":"Cancer Control"},{"key":"3436_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/his.12416","volume":"65","author":"H Go","year":"2014","unstructured":"Go H, Jeon YK, Huh J et al (2014) Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology 65:261\u2013272","journal-title":"Histopathology"},{"issue":"4","key":"3436_CR48","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/leu.2015.319","volume":"30","author":"M Kordes","year":"2016","unstructured":"Kordes M, R\u00f6ring M, Heining C et al (2016) Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling. Leukemia Apr 30(4):937\u2013946","journal-title":"Leukemia Apr"},{"key":"3436_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00428-016-1965-2","volume":"469","author":"Q Liu","year":"2016","unstructured":"Liu Q, Tomaszewicz K, Hutchinson L et al (2016) Somatic mutations in histiocytic sarcoma identified by next generation sequencing. Virchows Arch 469:233\u2013241","journal-title":"Virchows Arch"},{"key":"3436_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3816\/CLM.2002.n.019","volume":"3","author":"R Naumann","year":"2002","unstructured":"Naumann R, Beuthien-Baumann B, Fischer R et al (2002) Simultaneous occurrence of Hodgkin\u2019s lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging. Clin Lymphoma Myeloma Leuk 3:121\u2013124","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3436_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.humpath.2005.08.024","volume":"37","author":"LJ Christie","year":"2006","unstructured":"Christie LJ, Evans AT, Bray SE et al (2006) Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Hum Pathol 37:32\u201339","journal-title":"Hum Pathol"},{"key":"3436_CR52","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/modpathol.2016.235","volume":"30","author":"S Pina-Oviedo","year":"2017","unstructured":"Pina-Oviedo S, Medeiros LJ, Li S et al (2017) Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol 30:734\u2013744","journal-title":"Mod Pathol"},{"key":"3436_CR53","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1080\/10428190500160017","volume":"46","author":"MM Trebo","year":"2005","unstructured":"Trebo MM, Attarbaschi A, Mann G et al (2005) Histiocytosis following T-acute lymphoblastic leukemia: a BFM study. Leuk Lymphoma 46:1735\u20131741","journal-title":"Leuk Lymphoma"},{"key":"3436_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2350\/09-03-0622-OA.1","volume":"13","author":"EC Castro","year":"2010","unstructured":"Castro EC, Blazquez C, Boyd J et al (2010) Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol 13:225\u2013237","journal-title":"Pediatr Dev Pathol"},{"key":"3436_CR55","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3109\/10428191003699845","volume":"51","author":"E Wang","year":"2010","unstructured":"Wang E, Hutchinson CB, Huang Q et al (2010) Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular\/genetic evidence suggestive of a \u201ctransdifferentiation\u201d during the clonal evolution. Leuk Lymphoma 51:802\u2013812","journal-title":"Leuk Lymphoma"},{"key":"3436_CR56","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","volume":"24","author":"H Shao","year":"2011","unstructured":"Shao H, Xi L, Raffeld M, Feldman AL et al (2011) Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases. Mod Pathol 24:1421\u20131432","journal-title":"Mod Pathol"},{"key":"3436_CR57","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1600-0560.2011.01769.x","volume":"38","author":"W Zeng","year":"2011","unstructured":"Zeng W, Meck J, Cheson BD et al (2011) Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor. J Cutan Pathol 38:999\u20131003","journal-title":"J Cutan Pathol"},{"key":"3436_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000365396","volume":"81","author":"L Buser","year":"2014","unstructured":"Buser L, Bihl M, Rufle A et al (2014) Unique composite hematolymphoid tumor consisting of a pro-T lymphoblastic lymphoma and an indeterminate dendritic cell tumor: evidence for divergent common progenitor cell differentiation. Pathobiology 81:199\u2013205","journal-title":"Pathobiology"},{"key":"3436_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.humpath.2016.04.004","volume":"55","author":"S Fernandez-Pol","year":"2016","unstructured":"Fernandez-Pol S, Bangs CD, Cherry A et al (2016) Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol 55:39\u201343","journal-title":"Hum Pathol"},{"issue":"4","key":"3436_CR60","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/leu.2015.193","volume":"30","author":"E Waanders","year":"2016","unstructured":"Waanders E, Hebeda KM, Kamping EJ et al (2016) Independent development of lymphoid and histiocytic malignancies from a shared early precursor. Leukemia 30(4):955\u2013958","journal-title":"Leukemia"},{"issue":"6","key":"3436_CR61","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2350\/10-12-0950-CR.1","volume":"14","author":"A Bains","year":"2011","unstructured":"Bains A, Parham DM (2011) Langerhans cell histiocytosis preceding the development of juvenile xanthogranuloma: a case and review of recent developments. Pediatr Dev Pathol 14(6):480\u2013484","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"3436_CR62","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/1346-8138.14179","volume":"45","author":"Z Li","year":"2018","unstructured":"Li Z, Li Y, Liu W et al (2018) Mixed histiocytosis: a case report and published work review. J Dermatol 45(4):491\u2013495","journal-title":"J Dermatol"},{"key":"3436_CR63","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/PAS.0b013e318030a3b3","volume":"31","author":"D Janssen","year":"2007","unstructured":"Janssen D, F\u00f6lster-Holst R, Harms D, Klapper W (2007) Clonality in juvenile xanthogranuloma. Am J Surg Pathol 31:812\u2013813","journal-title":"Am J Surg Pathol"},{"key":"3436_CR64","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1182\/blood.V128.22.951.951","volume":"128","author":"BH Durham","year":"2016","unstructured":"Durham BH, Yoshimi A, Papo M et al (2016) Frequent clinical overlap of histiocytic neoplasms and WHO-classified myeloid malignancies leads to functional insights into the cell-of-origin of histiocytoses. Blood 128:951","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3436-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3436-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3436-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T08:55:47Z","timestamp":1604739347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3436-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":64,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3436"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3436-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"23 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}